KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Non-Current Assets (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Other Non-Current Assets for 16 consecutive years, with $4.2 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Other Non-Current Assets rose 1.36% year-over-year to $4.2 billion, compared with a TTM value of $4.2 billion through Sep 2024, up 1.36%, and an annual FY2023 reading of $4.0 billion, changed 0.2% over the prior year.
  • Other Non-Current Assets was $4.2 billion for Q3 2024 at Thermo Fisher Scientific, down from $4.4 billion in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $4.6 billion in Q4 2021 and bottomed at $2.0 billion in Q3 2020.
  • Average Other Non-Current Assets over 5 years is $3.5 billion, with a median of $4.0 billion recorded in 2022.
  • The sharpest move saw Other Non-Current Assets soared 88.85% in 2021, then dropped 13.64% in 2022.
  • Year by year, Other Non-Current Assets stood at $2.5 billion in 2020, then surged by 88.85% to $4.6 billion in 2021, then fell by 13.64% to $4.0 billion in 2022, then decreased by 0.2% to $4.0 billion in 2023, then rose by 4.53% to $4.2 billion in 2024.
  • Business Quant data shows Other Non-Current Assets for TMO at $4.2 billion in Q3 2024, $4.4 billion in Q2 2024, and $4.2 billion in Q1 2024.